Table S5 from Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms

Authors:

Abstract
List of BRCA1/2 deleterious (red) and reversion (blue) mutations summarized in Fig 3C.